29 research outputs found

    Environmental study of a methicillin-resistant Staphylococcus aureus epidemic in a burn unit.

    Get PDF
    During an outbreak of infections caused by methicillin-resistant (MR) Staphylococcus aureus in our burn unit, we conducted an extensive 10-week study to define the environmental epidemiology of the organism. The inanimate environment in patient rooms and adjacent areas was examined by using volumetric air samplers and Rodac plates. Airborne and surface level contamination with MR S. aureus was quantitated, and overall, MR S. aureus comprised 16, 31, and 40% of all bacterial growth from air, elevated surfaces, and floor surfaces, respectively. Mean air, elevated surface, and floor surface MR S. aureus contamination in rooms of MR S. aureus-infected burn patients were 1.9 MR S. aureus per ft3 (ca. 0.028 m3), 20 MR S. aureus per Rodac plate and 48 MR S. aureus per Rodac plate, respectively. Peak patient room environmental contamination levels were 6.9 MR S. aureus per ft3 of air, 70 MR S. aureus per Rodac plate per elevated surface and 138 MR S. aureus per Rodac plate per floor surface. Environmental contamination levels in the adjacent work areas were considerably lower than in infected patient rooms. There was ample opportunity for contamination of personnel through the inanimate environment in this unit

    Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations

    Get PDF
    Abstract Health care-associated infections (HAI) are a major public health problem with a significant impact on morbidity, mortality and quality of life. They represent also an important economic burden to health systems worldwide. However, a large proportion of HAI are preventable through effective infection prevention and control (IPC) measures. Improvements in IPC at the national and facility level are critical for the successful containment of antimicrobial resistance and the prevention of HAI, including outbreaks of highly transmissible diseases through high quality care within the context of universal health coverage. Given the limited availability of IPC evidence-based guidance and standards, the World Health Organization (WHO) decided to prioritize the development of global recommendations on the core components of effective IPC programmes both at the national and acute health care facility level, based on systematic literature reviews and expert consensus. The aim of the guideline development process was to identify the evidence and evaluate its quality, consider patient values and preferences, resource implications, and the feasibility and acceptability of the recommendations. As a result, 11 recommendations and three good practice statements are presented here, including a summary of the supporting evidence, and form the substance of a new WHO IPC guideline

    Surgical Site Infection as a Surrogate Marker of Physician Impairment

    No full text

    Comparative In Vitro Efficacies of Various Catheter Lock Solutions

    No full text
    MEDTA (minocycline-edetate calcium disodium), taurolidine (2%)-polyvinylpyrolidine (5%) (T/PVP), and ethanol as potential catheter lock solutions have a unique mechanism of action, broad-spectrum activity, and anticoagulant properties. Traditional lock solutions minocycline (M), rifampin (R), ciprofloxacin (C), and vancomycin, except pharmacologic concentrations of C and R and of M and R, were less effective than MEDTA and T/PVP
    corecore